Expression and purification of E140 protein antigen fragments of Plasmodium vivax and Plasmodium berghei for serological assays
Malaria, a life‐threatening disease caused by Plasmodium parasites, continues to pose a significant global health threat, with nearly 250 million infections and over 600 000 deaths reported annually by the WHO. Fighting malaria is particularly challenging partly due to the complex life cycle of the...
Saved in:
| Main Authors: | Rodolfo Ferreira Marques, Edit Ábrahám, Hiromi Muramatsu, Daniel Youssef Bargieri, Norbert Pardi, Zoltán Lipinszki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | FEBS Open Bio |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/2211-5463.13939 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in transmission-blocking vaccines against Plasmodium falciparum and Plasmodium vivax
by: Mayumi Tachibana, et al.
Published: (2025-12-01) -
Risk factor for gametocyte carriage and gametocytemia in Plasmodium vivax and Plasmodium falciparum
by: Minxi Li, et al.
Published: (2025-08-01) -
Genetic diversity of Plasmodium vivax and Plasmodium falciparum field isolates from Honduras in the malaria elimination phase
by: Alejandro Zamora, et al.
Published: (2025-01-01) -
Preliminary assessment of serum endocan as a biomarker of disease severity in Plasmodium falciparum and Plasmodium vivax malaria
by: Kwannan Nantavisai, et al.
Published: (2025-07-01) -
Immunogenicity of PvVir14-derived peptides to improve the serological diagnosis of Plasmodium vivax infection
by: Ramayana Morais de Medeiros Brito, et al.
Published: (2025-03-01)